Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKL27969 in advanced solid tumors
NCT05388435Phase 2Terminated
- Sponsor
- SK Life Science, Inc.
- Start
- Sep 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SKL27969 in solid tumor, sponsored by SK Life Science, Inc.. Started Sep 2022; status: terminated.
02
Drugs
SKL27969
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05388435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05388435.